2bPrecise Named “Best Overall Genomics Company” in 2023 MedTech Breakthrough Awards Program


Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies


[Houston, TX] – May 3, 2023 – 2bPrecise, a leading provider of transformative precision medicine solutions, today announced that it is the recipient of the “Best Overall Genomics Company” award in the 7th annual MedTech Breakthrough Awards. The program, conducted by MedTech Breakthrough – an independent market intelligence organization – recognizes the top companies, technologies, and products in the global health and medical technology market.

The 2bPrecise software platform provides health systems, municipal agencies, and care organizations with a suite of solutions that democratize access to genomic insights. 2bPrecise’s solutions for pharmacogenomics, oncology, and hereditary screening help providers more easily obtain and utilize the insights from laboratory diagnostic results across the entire care ecosystem. 2bPrecise also features pedigree and candidate management solutions to help population health managers easily and proactively identify opportunities for engagement.

In 2022, 2bPrecise expanded native support for more health systems, including the two largest global EMR vendors and a growing number of care-specific platforms serving the long-term care industry. Through in-workflow presentation and advanced analytical tools, such as the precision medicine timeline, 2bPrecise ensures that clinicians can easily reference the data elements from these tests for additional analysis or support of clinical research initiatives. In addition, 2bPrecise has recently added support for diagnostic ordering and resulting for hundreds of diagnostic tests from leading laboratories focused on oncology, rare diseases, and hereditary screening.

“We are committed to building and delivering solutions that lead the market and meet the needs of clinical partners, and this pace of innovation has only increased with our continued growth. Through our ongoing platform expansion, customer growth, and strategic investments in developing innovative software-based clinical workflow tools, we continue to realize our vision to enable transformative genomics solutions at the point of care,” said 2bPrecise Founder Assaf Halevy. “This recognition from MedTech Breakthrough reflects our dedication to the ever-evolving needs of clinical professionals with tools to help maximize the benefits of precision genomics.”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work, and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data, and many more. This year’s program attracted more than 4,000 nominations from over 17 countries worldwide.

“Personalized medicine is emerging as a standard of care across clinical applications. However, health systems are encountering complex logistics issues that prevent a seamless workflow of ordering, resulting, and alerting forcomplex molecular diagnostic tests. There are multiple barriers to easily and effectively delivering results and insights within the native EMR workflow,” said James Johnson, managing director of MedTech Breakthrough. “We’re thrilled to recognize 2bPrecise again as our ‘Best Overall Genomics Company’ as they continue to help close long-standing health disparity gaps and support turnkey programs that are enabling a new wave of successful, high-utility genomics programs.”


About 2bPrecise

The cloud-based 2bPrecise platform consumes genetic/genomic data from molecular labs and clinical information from EHRs, synthesizing them into a clinical-genomic ontology. The 2bPrecise Genomic EHR Mentor (GEM™) brings the resulting precision medicine insights into a physician’s EHR workflow for immediate and timely use. With discrete test results consolidated into an invaluable data set, provider organizations are likewise equipped to drive efficient workflows for genomic interventions, extract population analytics, design clinical intervention programs, build cohorts for trial recruitment, enable participation in research studies and more.

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Media Contact

Ashley DuBray
Senior Marketing Director